Mycelex OTC Side Effects
Generic name: clotrimazole topical
Medically reviewed by Drugs.com. Last updated on May 10, 2024.
Note: This document provides detailed information about Mycelex OTC Side Effects associated with clotrimazole topical. Some dosage forms listed on this page may not apply specifically to the brand name Mycelex OTC.
Applies to clotrimazole topical: topical cream, topical lotion, topical solution.
Serious side effects of Mycelex OTC
Along with its needed effects, clotrimazole topical (the active ingredient contained in Mycelex OTC) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking clotrimazole topical:
- Skin rash, hives, blistering, burning, itching, peeling, redness, stinging, swelling, or other sign of skin irritation not present before use of this medicine
For healthcare professionals
Applies to clotrimazole topical: compounding powder, topical cream, topical lotion, topical powder, topical solution, topical spray, vaginal cream with applicator, vaginal kit, vaginal tablet.
Dermatologic
Dermatologic side effects have included erythema, stinging, blistering, peeling, edema, itching, burning, and general skin irritation. Contact dermatitis, confirmed by patch testing, has been documented.[Ref]
Genitourinary
Genitourinary system effects associated with intravaginal use have included burning, itching, cramping, pain, and bleeding. Vulvar lesions and rash have rarely been reported.[Ref]
References
1. Roller JA (1978) "Contact allergy to clotrimazole." Br Med J, 2, p. 737
2. Balato N, Lembo G, Nappa P, Ayala F (1985) "Contact dermatitis from clotrimazole." Contact Dermatitis, 12, p. 110
3. Kalb RE, Grossman ME (1985) "Contact dermatitis to clotrimazole." Cutis, 36, p. 240-2
4. (2001) "Product Information. Mycelex (clotrimazole)." Bayer
5. Baes H (1995) "Contact dermatitis from clotrimazole." Contact Dermatitis, 32, p. 187-8
6. Lebherz T, Guess E, Wolfson N (1985) "Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis." Am J Obstet Gynecol, 152, p. 965-8
7. Wolfson N, Riley J, Samuels B, Singh JM (1981) "Clinical toxicology of clotrimazole when administered vaginally." Clin Toxicol, 18, p. 41-5
8. Pons V, Greenspan D, Debruin M (1993) "Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group." J Acquir Immune Defic Syndr, 6, p. 1311-6
9. Brown D Jr, Binder GL, Gardner HL, Wells J (1980) "Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis." Obstet Gynecol, 56, p. 121-3
10. Lebherz TB, Ford LC, Kleinkopf V (1981) "A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis." Clin Ther, 3, p. 344-8
11. Stein GE, Christensen S, Mummaw N (1991) "Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis." DICP, 25, p. 582-5
12. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery (1975) "Clotrimazole: a review of its antifungal activity and therapeutic efficacy." Drugs, 9, p. 424-47
Frequently asked questions
More about Mycelex OTC (clotrimazole topical)
- Compare alternatives
- Latest FDA alerts (2)
- Dosage information
- During pregnancy
- Drug class: topical antifungals
- Breastfeeding
Patient resources
Other brands
Lotrimin AF Athlete's Foot Cream, Mycelex, Lotrimin AF Jock Itch Cream, Gyne-Lotrimin, ... +4 more
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Mycelex OTC side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.